Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric praziquantel assessment for schistosomiasis in Bahia and Sergipe
RBR-86kcy37Phase 3Recruiting
- Sponsor
- Fiocruz Bahia
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of praziquantel in schistosomiasis and schistosomiasis mansoni (3 arms), sponsored by Fiocruz Bahia. Primary endpoint: Parasitological cure proportion. Started Dec 2024; status: recruiting.
02
Drugs
praziquantel
03
Conditions
schistosomiasisschistosomiasis mansoni
Beyond the preview
Go deeper on RBR-86kcy37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-86kcy37.